This afternoon we're taking part in the Food and Drug Administration's public hearing to discuss the online advertising of regulated medical products on the Internet. The two day hearing - being live cast and Tweeted - is intended to help guide the FDA's policy decisions, especially in the areas of social media tools and search.
We think it's an important conversation and we share their goal of better understanding how to promote medical products online in a non-misleading and balanced manner. That's why at today's FDA hearing, we proposed a new Google ad design for FDA-related approved products that highlights an extra line of text clearly stating important risks, with a link to even more information for consumers. We think this new format will help set a clear standard for advertisers and give users important information.
The Internet, and how people use it, has changed a lot since the FDA last examined access to online health information in 1996. On Google alone, we've seen health condition searches increase several times over. What this tells us is that people find health related searches - and the ads they return - useful. We think this new ad proposal for FDA-approved products will make those searches even more helpful.
Posted by Pablo Chavez, Managing Policy Counsel
2 comments:
Most of us are really concerned about our health…We do want a healthy body with the absence of diseases that could perform daily activities..This news is a big help for consumers like us…We could search in the web right medications for different diseases as well as its contraindication that are specifically approved by Foods and Drugs Authority…We can now be sure that the medications we are taking has no risk or harmful effects.
A major and of using WordPress is that themes will simply be changed to fit your preferences. you'll simply amendment the planning, colours and layout of the theme to match your criteria. The text can even be formatted in line with your liking. There are an entire heap of choices to settle on from.
ADS DIATAS KOTAK KOMENTAR
Post a Comment